After induction therapy for cryptococcal meningitis with liposomal amphotericin B and flucytosine, what is the next step in therapy?

After induction therapy for cryptococcal meningitis with liposomal amphotericin B and flucytosine, what is the next step in therapy?

• A. Fluconazole
• B. Voriconazole
• C. Itraconazole
• D. Amphotericin B

Answer: (A)

After induction therapy with liposomal amphotericin B and flucytosine, the next step is consolidation with fluconazole. This phase finishes clearing the infection while allowing a switch to an oral regimen. Fluconazole penetrates the CNS well, is easy to take, and has solid evidence as consolidation therapy for cryptococcal meningitis. Typical practice is about eight weeks of high-dose fluconazole for consolidation, followed by maintenance fluconazole to prevent relapse, especially in patients with HIV until immune function improves. Continuing amphotericin B would extend induction rather than move into consolidation, and voriconazole or itraconazole are not preferred choices for consolidation due to less established CNS efficacy and different toxicity profiles.

After induction therapy with liposomal amphotericin B and flucytosine, the next step is consolidation with fluconazole. This phase finishes clearing the infection while allowing a switch to an oral regimen. Fluconazole penetrates the CNS well, is easy to take, and has solid evidence as consolidation therapy for cryptococcal meningitis. Typical practice is about eight weeks of high-dose fluconazole for consolidation, followed by maintenance fluconazole to prevent relapse, especially in patients with HIV until immune function improves. Continuing amphotericin B would extend induction rather than move into consolidation, and voriconazole or itraconazole are not preferred choices for consolidation due to less established CNS efficacy and different toxicity profiles.